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Introduction
The establishment and maintenance of cell polarity are crucial 
for a diverse range of biological processes, including cell mi-
gration, asymmetric cell division, and epithelial morphogenesis. 
In contrast, loss of cell polarity correlates with a more invasive 
phenotype in cancer cells (Bilder, 2004; Igaki et al., 2006). Lgl 
(lethal giant larvae) was originally identifi  ed as a tumor sup-
pressor protein (Mechler et al., 1985) and has recently been 
shown to play an important role in cell polarity (Bilder et al., 
2000; Ohshiro et al., 2000; Peng et al., 2000). Although the mo-
lecular mechanism of how Lgl regulates cell polarity is not fully 
understood, Lgl has been shown to localize at the basal mem-
brane domain, and its activity is required for the specifi  cation 
of basal membrane identity. Lgl bears the characteristics of a 
molecular scaffold, with WD40 protein–protein interaction 
motifs at the N terminus, and has no known enzymatic activity. 
Its roles in cell polarity and tumor suppression are therefore 
likely to be mediated by protein–protein interactions. In fact, 
Lgl forms a complex with other cell polarity proteins, including 
aPKC and Par-6 (Betschinger et al., 2003; Plant et al., 2003; 
Yamanaka et al., 2003; Dollar et al., 2005; Yasumi et al., 2005). 
In the Lgl–atypical PKC (aPKC)–Par-6 complex, aPKC phos-
phorylates Lgl, which alters its conformation (Betschinger et al., 
2005), inhibiting its activity and causing it to dissociate from 
the apical membrane cortex. aPKC also phosphorylates other 
cell polarity proteins, and the aPKC-catalyzed phosphorylations 
play a crucial role in the regulation of cell polarity in various 
cell types (Etienne-Manneville and Hall, 2003; Hurov et al., 
2004; Sotillos et al., 2004; Suzuki et al., 2004). How the activity 
of aPKC itself is regulated, however, is not fully understood. In 
this study, we identify p32 as a novel Lgl binding protein that 
enhances the activity of aPKC.
Results and discussion
p32 is a novel mammalian Lgl2 (mLgl2) 
binding protein
To further understand the functional role of Lgl proteins, we 
used biochemical affi  nity purifi  cation to identify novel interacting 
proteins of mLgl. As bait, we used the C terminus of mLgl2 tagged 
with maltose binding protein (MBP). By applying rat kidney 
lysate to the fusion protein coupled to amylose resin beads, we 
purifi  ed a protein with a size of 30 kD (Fig. S1 A, left, available 
at http://www.jcb.org/cgi/content/full/jcb.200612022/DC1). No 
other mLgl2 binding proteins were identifi  ed. Mass spectrometric 
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gl (lethal giant larvae) plays an important role in cell 
polarity. Atypical protein kinase C (aPKC) binds to and 
phosphorylates Lgl, and the phosphorylation negatively 
regulates Lgl activity. In this study, we identify p32 as a 
novel Lgl binding protein that directly binds to a domain on 
mammalian Lgl2 (mLgl2), which contains the aPKC phos-
phorylation site. p32 also binds to PKCζ, and the three 
proteins form a transient ternary complex. When p32 is 
bound, PKCζ is stimulated to phosphorylate mLgl2 more 
efﬁ  ciently. p32 overexpression in Madin–Darby canine 
kidney cells cultured in a 3D matrix induces an expansion 
of the actin-enriched apical membrane domain and dis-
rupts cell polarity. Addition of PKCζ inhibitor blocks apical 
actin accumulation, which is rescued by p32 overexpres-
sion. p32 knockdown by short hairpin RNA also induces 
cell polarity defects. Collectively, our data indicate that p32 
is a novel regulator of cell polarity that forms a complex 
with mLgl2 and aPKC and enhances aPKC activity.
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analysis identifi  ed the 30-kD protein as p32 (gC1QR, gC1q-BP, 
and HABP1), which was fi  rst characterized as a splicing factor 
2–associated protein (Honore et al., 1993) but later described as 
a multifunctional chaperone protein (Storz et al., 2000). Western 
blotting with anti-p32 antibody confi  rmed the identity of the 
protein (Fig. S1 A, right).
To validate the interaction, we examined whether mLgl2 
and p32 were coimmunoprecipitated. GFP-mLgl2-WT (wild 
type) and Myc-p32 were coexpressed in human embryonic kidney 
(HEK) 293 cells and immunoprecipitated with either anti-GFP or 
anti-Myc antibody. Reciprocal coimmunoprecipitation of mLgl2 
and p32 was observed, confi  rming the interaction between the two 
proteins (Fig. 1 A). Myc-p32 was not coimmunoprecipitated with 
GFP alone (Fig. S1 B). mLgl1, another mammalian homologue 
of Lgl, was also coimmunoprecipitated with p32 (Fig. S1 C). We 
also demonstrated that endogenous p32 and mLgl2 proteins were 
coimmunoprecipitated from HEK293 cell lysate (Fig. 1 B). We 
further showed that the interaction between mLgl2 and p32 was 
direct, as recombinant His-p32 protein bound specifi  cally to 
MBP-mLgl2C-WT in an in vitro binding assay (Fig. 1 C).
mLgl2 binds to and is phosphorylated by aPKC (PKCλ and 
PKCζ). p32 has also been shown to interact with and regulate 
PKCs, including aPKC (Storz et al., 2000; Robles-Flores et al., 
2002). We therefore examined whether mLgl2, p32, and PKCζ 
form a trimeric complex. FLAG-mLgl2-WT and p32-GFP were 
coexpressed in HEK293 cells, and double immunoprecipita-
tion experiments were performed. We fi  rst immunoprecipitated 
with anti-FLAG antibody, which pulled down both endogenous 
PKCζ and p32-GFP together with FLAG-mLgl2 (Fig. 1 D). The 
immunoprecipitate was then eluted from the beads with FLAG 
peptide, and a second immunoprecipitation was performed us-
ing anti-GFP antibody. After the second immunoprecipitation, 
p32 remained bound to mLgl2 and PKCζ (Fig. 1 D). These 
results indicate that the three proteins form a trimeric complex. 
Using several truncation mutants, we showed that amino acids 
544–1027 of mLgl2 and the C terminus of p32 are responsible 
for the interaction (Fig. S1, D–F).
p32 binds to mLgl2 transiently 
and enhances PKC𝗇 activity
To investigate whether the phosphorylation status of mLgl2 in-
fl  uences its interaction with p32, we performed in vitro binding 
experiments (Fig. 2 A). Untreated and λ-phosphatase–treated 
MBP-mLgl2C-WT bound to endogenous p32 from HEK293 
cell lysates to a similar extent. Interestingly, MBP-mLgl2C-
WT that had been incubated with PKCζ at 4°C pulled down 
more p32 (Fig. 2 A). However, MBP-mLgl2C-WT incubated 
with PKCζ at 30°C did not show increased interaction with p32 
(Fig. 2 A). These data suggest that PKCζ enhances the inter-
action between mLgl2 and p32, but once mLgl2 is phosphor-
ylated by PKCζ, p32 is no longer able to effi  ciently interact 
with the complex. Comparable results were obtained using a 
recombinant p32 protein (Fig. S2 A, available at http://www
.jcb.org/cgi/content/full/jcb.200612022/DC1).
To further investigate the interaction between mLgl2, 
PKCζ, and p32, we performed immunoprecipitation experiments 
using WT (mLgl2-WT) and nonphosphorylatable (mLgl2-SA) 
forms of mLgl2, in the presence or absence of overexpressed 
PKCζ (Fig. 2 B). In the mLgl2-SA mutant, three serines in the 
conserved aPKC phosphorylation site were changed to alanine. 
Endogenous p32 from HEK293 cell lysates was coimmuno-
precipitated with both mLgl2-WT and mLgl2-SA (Fig. 2 B). 
Coexpression of GFP-PKCζ enhanced the interaction of p32 
with mLgl2-SA, but not with mLgl2-WT (Fig. 2 B). These data 
further support a key role of PKCζ and the phosphorylation sta-
tus of mLgl2 in the transient interaction between mLgl2 and p32. 
Figure 1.  p32 is a novel mLgl2 binding protein. 
(A) Reciprocal coimmunoprecipitation of mLgl2 
and p32. GFP-mLgl2-WT and Myc-p32 were 
expressed in HEK293 cells, and immunoprecipi-
tation was performed by using either anti-GFP 
or anti-Myc antibody, followed by Western 
blotting with anti-GFP and anti-Myc antibodies. 
(B) Coimmunoprecipitation of endogenous 
mLgl2 and p32 proteins. Immunoprecipitation 
was performed with anti-mLgl2 antibody from 
HEK293 cell lysate, followed by Western blot-
ting using anti-mLgl2 and anti-p32 antibodies. 
(C) Direct interaction between p32 and mLgl2. 
Recombinant MBP-mLgl2C-WT and His-p32 
proteins were incubated and pulled down using 
amylose resin beads, followed by Western blot-
ting using anti-MBP and anti-His antibodies. As 
controls, MBP-Rac-WT and His-Hakai were used. 
(D) Double immunoprecipitation of mLgl2 and 
p32 to analyze complex formation with PKCζ. 
FLAG-mLgl2-WT and p32-GFP were expressed 
in HEK293 cells. An initial immunoprecipita-
tion was performed using anti-FLAG antibody, 
followed by elution of immunoprecipitates with 
FLAG peptide. The eluates were subjected to a 
second immunoprecipitation using anti-GFP anti-
body. The ﬁ  rst and second immunoprecipitates 
were examined by Western blotting using anti-
FLAG, anti-GFP, and anti-PKCζ antibodies.P32 IS A NOVEL MLGL2 BINDING PROTEIN • BIALUCHA ET AL. 577
Overexpression of mLgl2 did not substantially affect the in-
teraction between p32 and PKCζ, suggesting that the binding 
of p32 to PKCζ is not affected by the presence of mLgl2 
(Fig. S2 B).
We next examined the effect of p32 binding on the activ-
ity of PKCζ using in vitro kinase assays. Approximately equal 
amounts of PKCζ were pulled down by immunoprecipitation 
with anti-p32 antibody from 3 ml of HEK293 cell lysate and 
with anti-PKCζ antibody from 100 μl of lysate (Fig. 2 C, top). 
Immunoprecipitates were incubated with a biotinylated PKCζ-
specifi  c peptide substrate and γ-[
32P]ATP. PKCζ immunopre-
cipitated with anti-p32 antibody phosphorylated the substrate 
 2.5 times more effi  ciently than PKCζ immunoprecipitated 
with anti-PKCζ antibody (Fig. 2 C), suggesting that the inter-
action with p32 enhances the catalytic activity of PKCζ. A spe-
cifi  c PKC inhibitor, Gö6983, suppressed phosphorylation of the 
peptide by p32 immunoprecipitates (Fig. S2 C) and other types 
of PKCs, such as PKCα (classical PKC) and PKCδ (novel PKC), 
did not effi  ciently phosphorylate the substrate under the condi-
tions used (Fig. S2 D). These data indicate that the increased 
phosphorylation of the peptide in the p32 immuno  precipitates 
is indeed due to enhanced aPKC activity.
As mLgl2 is a crucial target for phosphorylation by 
PKCζ, we examined whether the interaction with p32 affected 
the ability of PKCζ to phosphorylate mLgl2. We fi  rst immuno-
precipitated PKCζ with either anti-p32 or anti-PKCζ antibody 
as described in the previous paragraph. The immunoprecipitates 
were then incubated with MBP-mLgl2C-WT and γ-[
32P]ATP in 
the presence or absence of a PKCζ inhibitor. As seen with the 
peptide substrate, PKCζ bound to p32 was signifi  cantly more ef-
fi  cient at phosphorylating MBP-mLgl2C-WT than PKCζ alone 
(Fig. 2 D). Furthermore, the phosphorylation of MBP-mLgl2C-
WT was shown to be mediated by PKCζ, as the addition of the 
PKCζ inhibitor effi  ciently blocked the phosphorylation of MBP-
mLgl2C-WT (Fig. 2 D). In the absence of immunoprecipitates, 
MBP-mLgl2C-WT protein was not substantially phosphor-
ylated, indicating that there is no contaminating kinase present 
with the protein (unpublished data). We also showed that the 
PKCζ inhibitor did not suppress phosphorylation by other types 
of PKC, such as PKCα and PKCδ (Fig. S2 E), confi  rming the 
specifi  city of the inhibitor. These data indicate that p32 en-
hances the activity of PKCζ to phosphorylate mLgl2.
It was recently shown that one mechanism of regulating 
aPKC activity involves the small GTPase Cdc42; binding of GTP-
bound Cdc42 and Par-6 to aPKC enhances the activity of aPKC 
(Joberty et al., 2000; Lin et al., 2000; Qiu et al., 2000). In Droso-
phila melanogaster, however, Lgl is still phosphorylated by aPKC, 
even if the ability of Par-6 to bind to Cdc42 is abolished, indicating 
that Cdc42 is not required for the activation of aPKC in this system 
(Hutterer et al., 2004). We propose that p32 binding to mLgl2 and 
PKCζ is a novel mode of aPKC regulation that enhances its cata-
lytic activity, leading to increased mLgl2 phosphorylation.
p32 partially colocalizes with mLgl2, 
and overexpression of p32 affects the 
localization of mLgl2 in MDCK cells
Next, we examined the subcellular localization of endogenous 
p32 and mLgl2 proteins in MDCK cells. mLgl2 localized at the 
Figure 2.  p32 interacts with mLgl2 transiently 
and enhances PKC𝗇 activity. (A and B) The 
interaction of p32 with mLgl2 was examined 
in the presence or absence of PKCζ under dif-
ferent mLgl2 phosphorylation conditions. (A) 
MBP-mLgl2C-WT was incubated with PKCζ or 
λ-phosphatase at 30 or 4°C, followed by incu-
bation with HEK293 cell lysates and pull-down 
assay using amylose resin beads. PKCζ and 
endogenous p32 bound to MBP-mLgl2C-WT 
were examined by Western blotting using anti-
PKCζ and anti-p32 antibodies, respectively. The 
membrane was stained with Coomassie brilliant 
blue to visualize MBP-mLgl2C-WT. (B) FLAG-
mLgl2-WT or -SA was expressed in HEK293 
cells with or without coexpression of GFP-PKCζ. 
Immunoprecipitation was performed using 
anti-FLAG antibody, followed by Western blot-
ting with anti-FLAG, anti–phospho-mLgl2, anti-
PKCζ, and anti-p32 antibodies. (C) Binding of 
p32 enhances the activity of PKCζ to phos-
phorylate a PKCζ peptide substrate. PKCζ was 
immunoprecipitated from the indicated amounts 
of HEK293 cell lysate by using either anti-p32 or 
anti-PKCζ antibody. In vitro kinase assays were 
performed by incubating immunoprecipitates 
with PKCζ peptide substrate and γ-[
32P]ATP. Pep-
tide substrates were then collected by incubation 
with streptavidin beads, and the radioactivity 
of the beads was measured. Without peptide 
substrate, negligible radioactivity was measured using streptavidin beads alone. (D) Binding of p32 enhances the activity of PKCζ to phosphorylate mLgl2. 
Immunoprecipitations and in vitro kinase assays were performed as described, except that MBP-mLgl2C-WT was used as PKCζ substrate, and incubations 
were performed in the presence or absence of a PKCζ inhibitor. (C and D) The radioactive count by control IgG immunoprecipitate was subtracted from 
that by p32 and PKCζ immunoprecipitates. Phosphorylation reactions were duplicated for each experiment, and the results shown are representative of 
three independent experiments. Error bars indicate mean ± SD.JCB • VOLUME 178 • NUMBER 4 • 2007  578
plasma membrane as well as in the cytosol observed as small 
puncta, whereas p32 was accumulated along the plasma mem-
brane with some cytosolic localization (Fig. 3 A, top). We found 
that both proteins partially colocalized at the cortex region 
of the plasma membrane (Fig. 3 A, bottom), suggesting that 
the interaction may occur at the cortical region rather than in 
the cytosol.
We also examined the effect of overexpression of p32 
on the localization of mLgl2. We used MDCK cell lines that 
stably express p32-GFP in a tetracycline-inducible manner 
(Fig. S3 A, available at http://www.jcb.org/cgi/content/full/jcb
.200612022/DC1). In the absence of tetracycline, expression of 
p32-GFP was not induced and mLgl2 localized at the plasma 
membrane (Fig. 3 B, top), as observed in parental nontrans-
fected MDCK cells (not depicted). Upon the addition of tetra-
cycline, the expression of p32-GFP was induced and mLgl2 
dissociated from the cell cortex and localized to the cytosol 
(Fig. 3 B, bottom). These results further support a role for p32 
as a regulator of mLgl2.
Overexpression and knockdown 
of p32 disturb the normal polarization 
of MDCK cells
To investigate the functional role of p32 in cell polarity, we used 
a 3D MDCK cell culture system. First, we used the MDCK cell 
lines expressing p32-GFP in a tetracycline-inducible manner 
described in the previous paragraph. Noninduced MDCK cells 
grown in a collagen gel formed cysts with a regular lumen and 
well-defi  ned, F-actin–rich apical membrane domains (Fig. 4 A, 
top). PKCζ also localized to the apical membrane domains (Fig. 
4 A, top). However, upon the induction of p32-GFP expression, 
cysts showed striking morphological changes, with expanded 
apical membrane domains and irregularly shaped lumens (Fig. 
4 A, bottom). PKCζ no longer localized to the apical membrane 
domains, but instead concentrated at apical sites of cell–cell 
contacts. Interestingly, an expansion of the apical membrane 
domains into the basal membrane domains was also observed in 
mLgl1/2 knockdown MDCK cells (Yamanaka et al., 2006).
We next examined the effect of p32 overexpression on the 
localization of the adherens junction marker E-cadherin and the 
tight junction component zonula occludens-1 (ZO-1). Under 
noninduced conditions, E-cadherin localized in a well-defi  ned 
strip at the basolateral membrane. ZO-1 localized at the tight 
junction as a distinctive spot in close proximity to the internal 
lumen (Fig. 4 B, top). In cells induced to overexpress p32-GFP, 
the linear localization of E-cadherin at the basolateral mem-
brane domain was lost and E-cadherin localized more diffusely 
(Fig. 4 B, bottom). ZO-1 localization was also disturbed and no 
longer restricted to the tight junctions (Fig. 4 B, bottom). We 
quantifi  ed the cell polarity defects in p32-overexpressing cells 
by determining the percentage of cysts with regular apical actin 
enrichment and normal lumen formation (Fig. S3 B). Although 
77% of noninduced cysts had this normal phenotype, only 15% 
of the induced cysts did, supporting an involvement of p32 in 
cell polarity.
Because aPKC inhibition using dominant-negative mu-
tants in epithelial cells has been shown to cause a loss of apical 
membrane domain identity (Chalmers et al., 2005), we exam-
ined the effect of a cell-permeable PKCζ inhibitor on cell polar-
ity. In the presence of the PKCζ inhibitor, cysts failed to form 
normally, as indicated by the lack of apical actin enrichment, 
mislocalization of ZO-1, and failure to form lumens (Fig. 4 C, 
top images). To investigate whether the effect of p32 over-
expression on cell polarity involves PKCζ activation, we studied 
whether p32 overexpression could rescue the phenotype induced 
by the PKCζ inhibitor. As shown in Fig. 4 C (bottom images), 
overexpression of p32 partially reverted the defects in apical actin 
enrichment and lumen formation, but not in ZO-1 localization. 
We conclude that p32 regulates cell polarity at least in part by 
modulating PKCζ activity.
Finally, we examined whether the knockdown of p32 
affects epithelial cell polarity. We established MDCK cell lines 
stably expressing p32 short hairpin RNA (shRNA) in a tetra-
cycline-inducible manner. In these cells, the level of endogenous 
Figure 3.  p32 partially colocalizes with mLgl2, and overexpression of 
p32 affects the localization of mLgl2 in MDCK cells. (A) Immunoﬂ  uores-
cence analysis of endogenous mLgl2 and p32 proteins in MDCK cells. 
(B) Immunoﬂ  uorescence analysis of p32-GFP, mLgl2, and F-actin in MDCK 
cells stably expressing p32-GFP in a tetracycline-inducible manner. These 
results are representative of results from two independent clones of p32-
GFP MDCK cells. Bars, 10 μm.P32 IS A NOVEL MLGL2 BINDING PROTEIN • BIALUCHA ET AL. 579
p32 protein decreased by >90% in the presence of tetracycline 
(Fig. 4 D and Fig. S3 C). Even in the absence of tetracycline, a 
slight decrease in p32 expression was observed compared with 
nontransfected parental cells, which can sometimes be seen with 
the Tet-on expression system (Fig. 4 D, top). In the absence of 
tetracycline, p32 shRNA cells formed cysts where ZO-1 local-
ized at the subapical region (Fig. 4 D, second from top). In con-
trast, the addition of tetracycline induced cell polarity defects, 
as indicated by the mislocalization of ZO-1 to the basolateral 
and basal membrane domains (Fig. 4 D, second from top; more 
images are shown in Fig. S3 D). A similar mislocalization of 
ZO-1 to the basolateral membrane domain was also reported in 
MDCK cells overexpressing mLgl2 (Yamanaka et al., 2003). 
Statistical analysis showed a signifi  cant difference between tet 
(−) and tet (+) in p32 shRNA cells (Fig. 4 D, third panel). The 
slight increase of cell polarity defects in tet (−) p32 shRNA cells 
compared with those in parental cells may be due to decreased p32 
expression (Fig. 4 D, third panel). The expression of p32 shRNA 
also induced mislocalization of PKCζ to the basolateral mem-
brane domain or the cytosol (Fig. 4 D, bottom), further  suggesting 
Figure 4.  p32 expression level affects cell polarity of MDCK cells in 3D culture. (A and B) Immunoﬂ  uorescence analysis of cell polarity markers in p32-GFP 
MDCK cell cysts. MDCK cells stably expressing p32-GFP in a tetracycline-inducible manner were seeded in a collagen gel. Cells were either treated or not 
treated with tetracycline to induce p32-GFP expression. (A) Immunostaining was performed using anti-GFP and anti-PKCζ antibodies. Actin was visualized 
with TRITC-labeled phalloidin. Nuclei were stained with Hoechst dye. (B) Immunostaining was performed using anti-GFP, anti-E-cadherin, and anti–ZO-1 
antibodies. (C) Cell polarity defects in p32-overexpressing MDCK cells are linked to PKCζ activation. A cell-permeable PKCζ pseudosubstrate inhibitor was 
added to noninduced or p32-GFP–overexpressing cells. Immunostaining was performed using anti-GFP and –ZO-1 antibodies. Arrowheads indicate ecto-
pic localizations of ZO-1. These results are representative of results from two independent clones of p32-GFP MDCK cells. *, P < 0.05. (D) A knockdown 
of p32 induces cell polarity defects in p32 shRNA–expressing MDCK cells. (top) Western blotting with anti-p32, anti-PKCζ, or anti–α-tubulin antibody was 
performed using cell lysates from parental or p32 shRNA cells. (second and bottom panels) Immunoﬂ  uorescence analysis of cell polarity markers in p32 
shRNA MDCK cell cysts. Immunostaining was performed using TRITC-labeled phalloidin and anti–β-catenin, anti–ZO-1, and anti-PKCζ antibodies. These re-
sults are representative of results from two independent clones of p32 shRNA MDCK cells. (third panel) For statistical analysis, 20 cysts were examined in 
each experiment at day 6 or 9 after seeding, and the results represent the means ± SD of three independent experiments. *, P < 0.0015; **, P < 0.0005. 
Cysts were analyzed by confocal microscopy. Bars, 10 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  580
a role of p32 in regulating aPKC. Collectively, these data indi-
cate a physiological role of p32 in cell polarity.
The deregulation of cell polarity proteins often induces a 
more invasive phenotype in malignant tumors (Bilder, 2004; 
Igaki et al., 2006). In this study, we show that overexpression 
and knockdown of p32 disturb the normal polarization of 
MDCK cells (Fig. 4). Interestingly, p32 is overexpressed in thy-
roid, colon, pancreatic, gastric, esophageal, and lung adenocar-
cinoma, but not in their nonmalignant counterparts (Rubinstein 
et al., 2004). Furthermore, p32 is differentially expressed dur-
ing the progression of epidermal carcinoma and accumulates in 
metastatic islands (Ghosh et al., 2004). Our results suggest that 
p32 not only serves as a marker of malignant cells but also may 
function as an oncoprotein. The cell polarity defects observed in 
p32 knockdown cells further suggest that precisely controlled 
levels of p32 protein may be essential for normal polarization. 
In conclusion, we have identifi  ed p32 as a novel mLgl2-inter-
acting protein that forms a transient complex with mLgl2 and 
PKCζ. In this protein complex, p32 regulates cell polarity through 
its ability to enhance the kinase activity of PKCζ.
Materials and methods
Puriﬁ  cation of mLgl2 binding proteins from rat kidney
For each experiment, ﬁ  ve adult rats were killed and kidneys were dissected 
and homogenized in buffer A (5 mM Tris/HCl, pH 7.5, 320 mM sucrose, 
and 10 μM PMSF). The homogenate was fractionated as previously de-
scribed (Fujita et al., 1998), and the detergent fraction was applied to 
250 μl amylose resin beads (New England Biolabs, Inc.) coupled to 30 μg 
MBP-mLgl2C-WT or -SD. Beads were washed three times in buffer B (20 mM 
Hepes/NaOH, pH 7.4, 1 mM DTT, 5 mM MgCl2, 2% NP-40, 150 mM NaCl, 
and 10 μM PMSF) followed by elution using buffer B with 10 mM maltose. 
The eluted samples were separated by SDS-PAGE, and proteins were visu-
alized using SYPRO Ruby protein gel stain (Invitrogen). MBP-mLgl2–interacting 
proteins were excised from the gel, and the amino acid sequences were 
  determined by LC-MS/MS.
LC-MS/MS procedure
mLgl2-interacting protein gel bands were excised and in-gel digested with 
trypsin. The digest mixtures were separated by nanoscale liquid chromatogra-
phy (LC Packings) on reverse-phase C18 column (150 × 0.075 mm ID; ﬂ  ow 
rate 0.15 ml/min). The eluate was introduced directly into a Q-STAR Pulsar-i-
hybrid quadruple time of ﬂ  ight mass spectrometer (MDS Sciex). The spectra 
were searched against a National Center for Biotechnology Information non-
redundant database with MASCOT MS/MS Ions search (Matrix Science).
Immunoprecipitation, MBP-mLgl2 pull down, and Western blotting
Immunoprecipitation was performed as described before (Hogan et al., 
2004). When indicated, immunoprecipitates were incubated with 400 U 
λ-phosphatase (New England Biolabs, Inc.) in λ-phosphatase buffer (50 mM 
Tris/HCl, pH 7.5, 100 mM NaCl, 0.1 mM EGTA, 0.01% Brij 35, and 2 mM 
MgCl2) or 125 ng recombinant PKCζ (Calbiochem) in phosphorylation 
buffer (20 mM Tris/HCl, pH 7.5, 5 mM MgCl2, 1 mM EGTA, and 40 μM ATP) 
for 30 min at the indicated temperature. pFLAG-CMV2-mLgl1 was provided 
by T. Pawson (Mount Sinai Hospital, Toronto, Canada).
MBP-mLgl2 pull down from HEK293 lysates was performed as de-
scribed for immunoprecipitation, except that 10 μg MBP-mLgl2C-WT were 
conjugated to 50 μl amylose resin beads. Western blotting was performed 
as described previously (Hogan et al., 2004) with the exception that blots 
in Fig. 1 (A, B, and D), Fig. 2 (A, C, and D), Fig. S1 (A, C, and F), Fig. S2 
(A and B), and Fig. S3 (A and C) were visualized using an infrared detection 
system (Odyssey; Licor Bioscience). In experiments with recombinant pro-
teins, we used 1.6 μg His6-p32 and His6-Hakai and 10 μg MBP-mLgl2C-WT 
and MBP-Rac-WT proteins.
Cell culture
To obtain MDCK cell lines stably expressing p32-GFP in an inducible man-
ner, we used the tet-on system (Invitrogen). First, MDCK cells were transfected 
with pcDNA6/TR, followed by selection in a medium containing 5 μg ml
−1 
blasticidin. Then, pcDNA4/TO/p32-GFP was used for the second trans-
fection, and doubly transfected cells were selected in a tetracycline-free 
medium containing 5 μg ml
−1 blasticidin and 400 μg ml
−1 Zeocin. Induc-
tion of p32-GFP expression after addition of 2 μg/ml tetracycline was 
monitored over time and conﬁ  rmed by Western blotting. Four independent 
clones were obtained. To obtain MDCK cell lines stably expressing p32 
shRNA in a tetracycline-inducible manner, the same procedure was per-
formed, except that pSUPERIOR-p32 shRNA was used for the second trans-
fection and 800 μg ml
−1 G418 was added to the medium for selection. 
Three independent clones were obtained.
Immunoﬂ  uorescence
Cysts were processed for immunoﬂ  uorescence staining as described previ-
ously (O’Brien et al., 2001). Rabbit anti–mLgl2-S653P-2 antibody was 
provided by S. Ohno (Yokohama City University, Yokohama, Japan). Cysts 
were mounted using ProLong Gold Antifade reagent (Invitrogen) and ana-
lyzed on a confocal microscope (TCS SP5; Leica) with a 63× NA 1.4 oil-
immersion objective at room temperature (Leica). 65 z sections at 1-μm 
intervals were captured per cyst, and images were acquired using the Leica 
Application Suite. Images shown are single sections through the center of 
the cysts. Images were colorized and contrast was enhanced linearly using 
the Volocity software package (Improvision), and brightness was adjusted 
using Photoshop CS (Adobe). For the statistical analysis of cell polarity de-
fects, noninduced and p32-GFP–overexpressing MDCK cell cysts were ana-
lyzed at room temperature using a microscope (DM IRB; Leica) with a 10× 
0.25 air objective (Leica). Images were captured using a camera (Orca; 
Hamamatsu) and Openlab software (Improvision). Secondary antibodies 
used were goat anti-mouse Alexa 488 and goat anti-rabbit Alexa 647 
(Invitrogen), as well as goat anti-rat Rhodamine Red-X (Jackson Immuno-
Research Laboratories). To visualize actin and nuclei, we used TRITC-labeled 
phalloidin (Sigma-Aldrich) and Hoechst 33342 (Invitrogen), respectively.
MDCK 3D cell culture and PKC𝗇 inhibition
3D cell culture was performed as described previously (O’Brien et al., 
2001) except that chamberslides (BD Biosciences) were used instead of ﬁ  l-
ter inserts. In brief, MDCK cells were seeded into a 2 mg/ml collagen-I gel 
at a concentration of 2.5 × 10
5 cells/ml, covered with 500 μl of culture 
medium and cultured for 6 or 9 d. For induction of p32-GFP expression, the 
culture medium was supplied with 2 μg/ml tetracycline from day 1, and the 
medium was replaced daily. For inhibition of PKCζ, a cell-permeable myris-
toylated PKCζ pseudosubstrate inhibitor (Biosource International) was added 
to cysts at a concentration of 25 μM from day 1. Before these experiments, 
we titrated the concentration of the inhibitor (25, 50, and 100 μM) to ob-
tain an optimal condition where cell polarity was disturbed without cytotox-
icity. For p32 knockdown, cells were supplied with tetracycline for 3 d before 
seeding into a collagen gel, and the medium was replaced daily.
In vitro kinase assays
After immunoprecipitation, samples were incubated in 60 μl phosphory-
lation buffer with 9 μCi γ-[
32P]ATP and either 40 μM biotinylated PKCζ 
peptide substrate or 200 ng MBP-mLgl2C-WT at 30°C for 5 min. 100 nM 
Gö6983 (Calbiochem) or 0.5 mM PKCζ pseudosubstrate inhibitor (Calbio-
chem) was added when indicated. The kinetics of mLgl2 phosphorylation 
by endogenous PKCζ was ﬁ  rst determined, and a 5-min incubation time 
was used for all experiments. After the kinase reaction, 50 μl of the re-
action buffer was incubated with either 20 μl streptavidin agarose (Sigma-
Aldrich) or 50 μl amylose resin (New England Biolabs, Inc.) at 4°C for 30 
min, followed by intensive washing. Radioactivity of the beads was mea-
sured using Cerenkov counting in a liquid scintillation analyzer (1900-TR; 
Packard Instrument Co.). For Fig. S2 E, phosphorylation by PKCα and 
PKCδ was performed as described previously (Fujita et al., 1996). After 
phosphorylation, the reaction was stopped by addition of 30 mM NaF and 
100 mM EDTA, and the phosphorylated substrate was spotted onto P81 
paper (Whatman), followed by intensive washing in 75 mM H3PO4 and 
Cerenkov counting. The recombinant PKCα and PKCζ were purchased 
from Calbiochem, and PKCδ was obtained from Sigma-Aldrich.
Statistical analysis
t tests assuming equal or unequal variance were performed for statisti-
cal analysis.
Online supplemental material
Fig. S1 shows characterization of the interaction between mLgl2 and 
p32. Fig. S2 shows that p32 interacts with mLgl2 transiently and   enhances 
PKCζ activity. Fig. S3 shows that p32 expression level affects cell polarity P32 IS A NOVEL MLGL2 BINDING PROTEIN • BIALUCHA ET AL. 581
of MDCK cells in 3D culture. The supplemental text provides details about 
the generation of plasmid constructs and sources of antibodies. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200612022/DC1.
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